Extended dosing intervals for Euvichol-S oral cholera vaccine in participants aged one year and older in Nairobi, Kenya: supporting documents for a phase IV randomized non-inferiority trial protocol
Domain:
healthcareCreator:
OsoMbaDoyKim
Publisher:
Host:
This record contains supporting documents for the study protocol, “Extended dosing intervals for Euvichol-S oral cholera vaccine in participants aged one year and older in Nairobi, Kenya: protocol for a phase IV randomized non-inferiority trial.”
The trial is being conducted in Mukuru, Nairobi, Kenya, and compares second-dose Euvichol-S intervals of two weeks, three months, and twelve months among participants aged one year and older. The trial is registered with the Pan African Clinical Trials Registry (PACTR202501835187008).
The deposited files comprise the approved study protocol, version 1.2 dated 31 July 2025, the completed SPIRIT 2025 checklist, and the completed TIDieR checklist.
Similar
Data for: Non- inferiority fractional-doses trial for yellow fever vaccine (NIFTY Trial)IMPACT OF DOSING REGIMEN ON CONSUMPTION OF CALCIUM SUPPLEMENTS FOR PREVENTION OF PREECLAMPSIA AMONG ANTENATAL CARE CLIENTS: A CLUSTER‐RANDOMIZED, NON‐INFERIORITY TRIAL IN WESTERN KENYAReplication Data for: A Single Dose Oral Azithromycin versus Intramuscular Benzathine Penicillin for the Treatment of Yaws-A Randomized Non Inferiority Trial in GhanaSequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trialComparing time to recovery in wasting treatment: simplified approach vs. standard protocol among children aged 6–59 months in Ethiopia—a cluster-randomized, controlled, non-inferiority trialCommunity case management of chest indrawing pneumonia in children aged 2 to 59 months by community health workers: study protocol for a multi-country cluster randomized open label non-inferiority trial